BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats
Objectives: Nanoparticles can be employed to improve the therapeutic activity of natural products. Type 2 diabetes mellitus is a serious health condition that has spread like a "modern pandemic" worldwide. In the present study, we developed silver nanoparticles, Ag-NPs, with an aqueous ex...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2023
|
| In: |
Current pharmaceutical biotechnology
Year: 2023, Volume: 24, Issue: 14, Pages: 1812-1826 |
| ISSN: | 1873-4316 |
| DOI: | 10.2174/1389201024666230313105049 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://dx.doi.org/10.2174/1389201024666230313105049 Verlag, lizenzpflichtig, Volltext: https://www.eurekaselect.com/article/130114 |
| Author Notes: | Yasser Omar Mosaad, Mohammed Abdalla Hussein, Hayam Ateyya, Soha Ahmed Hassan, Michael Wink, Naglaa Abd El Khalik Gobba and Zahraa Nassar Mohamed |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1860859259 | ||
| 003 | DE-627 | ||
| 005 | 20240307051821.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231006s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389201024666230313105049 |2 doi | |
| 035 | |a (DE-627)1860859259 | ||
| 035 | |a (DE-599)KXP1860859259 | ||
| 035 | |a (OCoLC)1425210800 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Mosaad, Yasser O. |e VerfasserIn |0 (DE-588)1293415898 |0 (DE-627)1850741271 |4 aut | |
| 245 | 1 | 0 | |a BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats |c Yasser Omar Mosaad, Mohammed Abdalla Hussein, Hayam Ateyya, Soha Ahmed Hassan, Michael Wink, Naglaa Abd El Khalik Gobba and Zahraa Nassar Mohamed |
| 264 | 1 | |c 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 28. April 2023 | ||
| 500 | |a Gesehen am 06.10.2023 | ||
| 520 | |a Objectives: Nanoparticles can be employed to improve the therapeutic activity of natural products. Type 2 diabetes mellitus is a serious health condition that has spread like a "modern pandemic" worldwide. In the present study, we developed silver nanoparticles, Ag-NPs, with an aqueous extract from Balanites aegyptiaca to investigate their antioxidant and anti-inflammatory activity in STZ-induced diabetic rats. Methods: Aqueous extracts of Balanites aegyptiaca seeds (BAAE) were used in the synthesis of BAAE-AgNPs, which were characterized using FTIR and TEM. Different doses of BAAE-AgNP (1/50 LD50; 29.4 mg/kg b.w. and 1/20 LD50: 73.5 mg/kg b.w.) were administered to STZ-induced diabetic rats to evaluate their potential antidiabetic activity. Results: FTIR spectral data indicated the presence of flavonoids and polyphenols in BAAEAgNPs. The size of the BAAE-AgNPs, determined by TEM examination, was 49.33 ± 7.59 nm, with a zeta potential of +25.37. BAAE-AgNPs were characterized by an LD50 value of 1470 mg/kg b.w. In diabetic rats, the daily oral administration of both doses of BAAE-AgNPs (29.4 and 73.5 mg/kg b.w.) for 12 weeks resulted in a significant improvement in body weight, insulin homeostasis, HbA1c, HDL-C, MDA, and pancreatic SOD, CAT, and GSH. They reduced plasma glucose, cholesterol, and triglycerides. This treatment also resulted in a significant decrease in pancreatic IL-6, p53, and TNF-α in diabetic rats. Furthermore, BAAE-AgNPs down-regulated pancreatic TGF-β1 and Akt gene expression in diabetic rats and resulted in a significant decrease in the regulation of hepatic GLUT-2, as well as an increase in the regulation of hepatic GK and pancreatic B-cl2 gene expression. The histopathological results obtained indicated that BAAEAgNPs improved pancreatic tissue metabolism by enhancing antioxidant enzymes, suppressing inflammatory cytokines, and scavenging free radicals. Conclusion: The findings implied that similar to the glibenclamide-treated groups, in the BAAEAgNPs treated group, the compromised antioxidant status normalized in STZ-induced diabetes. By scavenging free radicals, BAAE-Ag-NPs protected against lipid peroxidation while reducing the risk of complications from diabetes. Compared to the daily dose of 29.4 mg, the impact was more prominent at 73.5 mg. | ||
| 700 | 1 | |a Hussein, Mohammed Abdalla |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ateyya, Hayam |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hassan, Soha Ahmed |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wink, Michael |d 1951- |e VerfasserIn |0 (DE-588)124618146 |0 (DE-627)363448519 |0 (DE-576)164659390 |4 aut | |
| 700 | 1 | |a Gobba, Naglaa Abd El Khalik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mohamed, Zahraa Nassar |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical biotechnology |d Hilversum : Bentham Science Publ., 2000 |g 24(2023), 14, Seite 1812-1826 |h Online-Ressource |w (DE-627)327962445 |w (DE-600)2044611-1 |w (DE-576)273880926 |x 1873-4316 |7 nnas |a BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:14 |g pages:1812-1826 |g extent:15 |a BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats |
| 856 | 4 | 0 | |u https://dx.doi.org/10.2174/1389201024666230313105049 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.eurekaselect.com/article/130114 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20231006 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 124618146 |a Wink, Michael |m 124618146:Wink, Michael |d 160000 |d 160100 |e 160000PW124618146 |e 160100PW124618146 |k 0/160000/ |k 1/160000/160100/ |p 5 | ||
| 999 | |a KXP-PPN1860859259 |e 4381788133 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Yasser Omar Mosaad, Mohammed Abdalla Hussein, Hayam Ateyya, Soha Ahmed Hassan, Michael Wink, Naglaa Abd El Khalik Gobba and Zahraa Nassar Mohamed"]},"id":{"doi":["10.2174/1389201024666230313105049"],"eki":["1860859259"]},"recId":"1860859259","physDesc":[{"noteIll":"Illustrationen","extent":"15 S."}],"origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 15.04.2024"],"id":{"zdb":["2044611-1"],"eki":["327962445"],"issn":["1873-4316"]},"part":{"volume":"24","year":"2023","issue":"14","extent":"15","text":"24(2023), 14, Seite 1812-1826","pages":"1812-1826"},"title":[{"title_sort":"Current pharmaceutical biotechnology","title":"Current pharmaceutical biotechnology","subtitle":"the international journal for timely in-depth reviews in pharmaceutical biotechnology"}],"origin":[{"dateIssuedDisp":"2000-","dateIssuedKey":"2000","publisherPlace":"Hilversum","publisher":"Bentham Science Publ."}],"pubHistory":["1.2000 -"],"disp":"BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic ratsCurrent pharmaceutical biotechnology","physDesc":[{"extent":"Online-Ressource"}],"recId":"327962445"}],"person":[{"given":"Yasser O.","role":"aut","family":"Mosaad","display":"Mosaad, Yasser O."},{"display":"Hussein, Mohammed Abdalla","family":"Hussein","given":"Mohammed Abdalla","role":"aut"},{"family":"Ateyya","given":"Hayam","role":"aut","display":"Ateyya, Hayam"},{"family":"Hassan","given":"Soha Ahmed","role":"aut","display":"Hassan, Soha Ahmed"},{"family":"Wink","role":"aut","given":"Michael","display":"Wink, Michael"},{"given":"Naglaa Abd El Khalik","role":"aut","family":"Gobba","display":"Gobba, Naglaa Abd El Khalik"},{"display":"Mohamed, Zahraa Nassar","family":"Mohamed","given":"Zahraa Nassar","role":"aut"}],"title":[{"title_sort":"BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats","title":"BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Online veröffentlicht: 28. April 2023","Gesehen am 06.10.2023"]} | ||
| SRT | |a MOSAADYASSBAAEAGNPSI2023 | ||